Recombinant Human HLA-C Protein，His

HLA-C (Human Leukocyte Antigen-C) is a critical component of the Major Histocompatibility Complex (MHC) class I molecules, which play a vital role in the immune response by presenting intracellular peptides to CD8+ T cells. This ability directly influences the recognition of infected or malignant cells, making HLA-C essential in both immune defense and transplantation immunology. Recent studies have shown that variations in HLA-C alleles are associated with different immune responses to pathogens, as well as with susceptibility to autoimmune diseases and the success of organ transplants. Therefore, understanding HLA-C's structure and function is paramount for developing targeted immunotherapies. Recombinant proteins of HLA-C are increasingly being utilized in research to elucidate its interactions with T cell receptors and to assess its role in immune evasion mechanisms employed by tumors and viruses. Furthermore, these recombinant proteins can serve as valuable tools for vaccine development and personalized medicine approaches by aiding in the identification of specific epitopes that can enhance T cell responses. The advances in genetic engineering technologies have facilitated the production of stable and functional HLA-C recombinant proteins, opening new avenues for experimental and clinical research aimed at harnessing the immune system to fight diseases. Overall, the exploration of HLA-C recombinant proteins can provide insights into immune regulation and pave the way for novel therapeutic strategies in infectious diseases, cancer, and autoimmune disorders.